Search Results

There are 111488 results for: content related to: Impact of pretransplant rifaximin therapy on early post–liver transplant infections

  1. You have free access to this content
    Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers’ diarrhoea

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 11, June 2010, Pages: 1155–1164, P. LAYER and V. ANDRESEN

    Version of Record online : 11 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04296.x

  2. You have free access to this content
    Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue S1, January 2016, Pages: 11–26, J. S. Bajaj

    Version of Record online : 30 NOV 2015, DOI: 10.1111/apt.13435

  3. The Effect of Multiple-Dose, Oral Rifaximin on the Pharmacokinetics of Intravenous and Oral Midazolam in Healthy Volunteers

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 10, October 2007, Pages: 1361–1369, Dr. Helen S. Pentikis, Dr. Margaret Connolly, Dr. Carol B. Trapnell, Dr. William P. Forbes and Dr. Doug K. Bettenhausen

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.10.1361

  4. Rifaximin for the Treatment of Hepatic Encephalopathy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 8, August 2008, Pages: 1019–1032, Dr. Kenneth R. Lawrence and Dr. Jacqueline A. Klee

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.8.1019

  5. You have free access to this content
    Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue S1, January 2016, Pages: 37–49, M. Pimentel

    Version of Record online : 30 NOV 2015, DOI: 10.1111/apt.13437

  6. Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 36, Issue 3, March 2016, Pages: 300–316, Anastasia Rivkin and Sergey Rybalov

    Version of Record online : 11 MAR 2016, DOI: 10.1002/phar.1712

  7. Rifaximin antibiotic treatment for restless legs syndrome: a double-blind, placebo-controlled study

    Sleep and Biological Rhythms

    Volume 10, Issue 2, April 2012, Pages: 145–153, Leonard B WEINSTOCK and Suzie ZEISS

    Version of Record online : 4 MAR 2012, DOI: 10.1111/j.1479-8425.2012.00537.x

  8. You have free access to this content
    The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy – a decision analysis

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 8, October 2007, Pages: 1147–1161, E. HUANG, E. ESRAILIAN and B. M. R. SPIEGEL

    Version of Record online : 9 AUG 2007, DOI: 10.1111/j.1365-2036.2007.03464.x

  9. Rifaximin exerts beneficial effects in PI-IBS mouse model beyond gut microbiota

    Journal of Gastroenterology and Hepatology

    Accepted manuscript online: 1 JUN 2017, Yu Jin, Xiaoyang Ren, Gangping Li, Ying Li, Lei Zhang, Huan Wang, Wei Qian and Xiaohua Hou

    DOI: 10.1111/jgh.13841

  10. Determination of rifaximin in rat serum by ionic liquid based dispersive liquid–liquid microextraction combined with RP-HPLC

    Journal of Separation Science

    Volume 35, Issue 15, August 2012, Pages: 1945–1952, Ramisetti Nageswara Rao, Rajavarapu Mastan Vali and Alamanda Vara Prasada Rao

    Version of Record online : 2 JUL 2012, DOI: 10.1002/jssc.201200202

  11. Rifaximin has minor effects on bacterial composition, inflammation and bacterial translocation in cirrhosis; A randomized trial

    Journal of Gastroenterology and Hepatology

    Accepted manuscript online: 3 JUL 2017, Nina Kimer, Julie S Pedersen, Juliette Tavenier, Jeffrey E Christensen, Troels M Busk, Lise Hobolth, Aleksander Krag, Waleed Abu Al-Soud, Martin S Mortensen, Søren J Sørensen, Søren Møller, Flemming Bendtsen and And members of the CoRif study group

    DOI: 10.1111/jgh.13852

  12. You have free access to this content
    Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 8, October 2010, Pages: 1000–1006, M. Furnari, A. Parodi, L. Gemignani, E. G. Giannini, S. Marenco, E. Savarino, L. Assandri, V. Fazio, D. Bonfanti, S. Inferrera and V. Savarino

    Version of Record online : 18 AUG 2010, DOI: 10.1111/j.1365-2036.2010.04436.x

  13. Does low-dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study

    Journal of Digestive Diseases

    Volume 16, Issue 11, November 2015, Pages: 665–674, Xin Zeng, Xia Jiao Tang, Xia Sheng, Wu Ni, Hai Guang Xin, Wei Zhong Chen, Cai Feng Jiang, Yong Lin, Jian Shi, Bin Shi, Yue Xiang Chen, Zong Li Yuan and Wei Fen Xie

    Version of Record online : 29 DEC 2015, DOI: 10.1111/1751-2980.12294

  14. You have free access to this content
    Review article: the antimicrobial effects of rifaximin on the gut microbiota

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue S1, January 2016, Pages: 3–10, H. L. DuPont

    Version of Record online : 30 NOV 2015, DOI: 10.1111/apt.13434

  15. You have free access to this content
    Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 8, October 2013, Pages: 925–934, S. C. Shah, L. W. Day, M. Somsouk and J. L. Sewell

    Version of Record online : 4 SEP 2013, DOI: 10.1111/apt.12479

  16. You have free access to this content
    Drug therapy: Rifaximin

    Hepatology

    Volume 52, Issue 4, October 2010, Pages: 1484–1488, Jasmohan S. Bajaj and Oliviero Riggio

    Version of Record online : 29 JUL 2010, DOI: 10.1002/hep.23866

  17. You have free access to this content
    Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy

    Alimentary Pharmacology & Therapeutics

    Volume 46, Issue 9, November 2017, Pages: 845–855, S. H. Kang, Y. B. Lee, J.-H. Lee, J. Y. Nam, Y. Chang, H. Cho, J.-J. Yoo, Y. Y. Cho, E. J. Cho, S. J. Yu, M. Y. Kim, Y. J. Kim, S. K. Baik and J.-H. Yoon

    Version of Record online : 24 AUG 2017, DOI: 10.1111/apt.14275

  18. You have full text access to this OnlineOpen article
    Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 10, May 2014, Pages: 1161–1168, P. Schoenfeld, M. Pimentel, L. Chang, A. Lembo, W. D. Chey, J. Yu, C. Paterson, E. Bortey and W. P. Forbes

    Version of Record online : 3 APR 2014, DOI: 10.1111/apt.12735

  19. Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial

    Hepatology

    Volume 65, Issue 2, February 2017, Pages: 592–603, Nina Kimer, Julie Steen Pedersen, Troels Malte Busk, Lise Lotte Gluud, Lise Hobolth, Aleksander Krag, Søren Møller, Flemming Bendtsen and Copenhagen Rifaximin (CoRif) Study Group

    Version of Record online : 24 DEC 2016, DOI: 10.1002/hep.28898

  20. You have free access to this content
    Efficacy of Rifaximin in Prevention of Travelers' Diarrhea: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials

    Journal of Travel Medicine

    Volume 19, Issue 6, December 2012, Pages: 352–356, Yangmin Hu, Jing Ren, Mei Zhan, Wenlu Li and Haibin Dai

    Version of Record online : 14 SEP 2012, DOI: 10.1111/j.1708-8305.2012.00650.x